227 related articles for article (PubMed ID: 15120566)
1. COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat.
Patel HH; Hsu AK; Gross GJ
Life Sci; 2004 May; 75(2):129-40. PubMed ID: 15120566
[TBL] [Abstract][Full Text] [Related]
2. COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts.
Shinmura K; Nagai M; Tamaki K; Tani M; Bolli R
Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2534-43. PubMed ID: 12388283
[TBL] [Abstract][Full Text] [Related]
3. COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism.
Jiang X; Shi E; Nakajima Y; Sato S
Life Sci; 2006 Apr; 78(22):2543-9. PubMed ID: 16325209
[TBL] [Abstract][Full Text] [Related]
4. BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation.
Patel HH; Hsu A; Moore J; Gross GJ
J Mol Cell Cardiol; 2001 Aug; 33(8):1455-65. PubMed ID: 11448134
[TBL] [Abstract][Full Text] [Related]
5. Gender and aging do not impair opioid-induced late preconditioning in rats.
Shinmura K; Nagai M; Tamaki K; Bolli R
Basic Res Cardiol; 2004 Jan; 99(1):46-55. PubMed ID: 14685705
[TBL] [Abstract][Full Text] [Related]
6. 12-lipoxygenase in opioid-induced delayed cardioprotection: gene array, mass spectrometric, and pharmacological analyses.
Patel HH; Fryer RM; Gross ER; Bundey RA; Hsu AK; Isbell M; Eusebi LO; Jensen RV; Gullans SR; Insel PA; Nithipatikom K; Gross GJ
Circ Res; 2003 Apr; 92(6):676-82. PubMed ID: 12623876
[TBL] [Abstract][Full Text] [Related]
7. Delayed cardioprotection is mediated via a non-peptide delta opioid agonist, SNC-121, independent of opioid receptor stimulation.
Patel HH; Hsu A; Gross GJ
Basic Res Cardiol; 2004 Jan; 99(1):38-45. PubMed ID: 14685704
[TBL] [Abstract][Full Text] [Related]
8. Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits.
Kodani E; Xuan YT; Shinmura K; Takano H; Tang XL; Bolli R
Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H1943-57. PubMed ID: 12384473
[TBL] [Abstract][Full Text] [Related]
9. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning.
Shinmura K; Xuan YT; Tang XL; Kodani E; Han H; Zhu Y; Bolli R
Circ Res; 2002 Mar; 90(5):602-8. PubMed ID: 11909825
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice.
Zhao T; Xi L; Chelliah J; Levasseur JE; Kukreja RC
Circulation; 2000 Aug; 102(8):902-7. PubMed ID: 10952960
[TBL] [Abstract][Full Text] [Related]
12. The role of selective nitric oxide synthase inhibitor on nitric oxide and PGE2 levels in refractory hemorrhagic-shocked rats.
Md S; Moochhala SM; Siew Yang KL; Lu J; Anuar F; Mok P; Ng KC
J Surg Res; 2005 Feb; 123(2):206-14. PubMed ID: 15680380
[TBL] [Abstract][Full Text] [Related]
13. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene.
Nagayama M; Niwa K; Nagayama T; Ross ME; Iadecola C
J Cereb Blood Flow Metab; 1999 Nov; 19(11):1213-9. PubMed ID: 10566967
[TBL] [Abstract][Full Text] [Related]
14. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
[TBL] [Abstract][Full Text] [Related]
16. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase].
Shi EY; Jiang XJ; Bai H; Nakajima Y
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):891-5. PubMed ID: 15329271
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2.
Wang Y; Kodani E; Wang J; Zhang SX; Takano H; Tang XL; Bolli R
Circ Res; 2004 Jul; 95(1):84-91. PubMed ID: 15166094
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo: evidence from pharmacologic inhibition and gene-knockout mice.
Jiang X; Shi E; Nakajima Y; Sato S
Anesthesiology; 2004 Jul; 101(1):82-8. PubMed ID: 15220775
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.
Bolli R; Shinmura K; Tang XL; Kodani E; Xuan YT; Guo Y; Dawn B
Cardiovasc Res; 2002 Aug; 55(3):506-19. PubMed ID: 12160947
[TBL] [Abstract][Full Text] [Related]
20. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
